Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The LEADLESS II IDE Study (Phase II): A Safety and Effectiveness Trial for a Leadless Pacemaker System

NCT04559945 is registered in ClinicalTrials.gov with Abbott Medical Devices as lead sponsor.

NCT NCT04559945
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04559945 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The LEADLESS II IDE Study (Phase II): A Safety and Effectiveness Trial for a Leadless Pacemaker System
Lead sponsor
Abbott Medical Devices
Phase
Not applicable
Overall status
Completed
Start date
November 13, 2020
Completion date
September 15, 2023
Enrollment
1,276 (actual)
Sites
53

Conditions

As the registry lists them; a condition with its own page is linked.

bradycardia, cardiac rhythm disorder